80 related articles for article (PubMed ID: 569013)
1. Selective reduction of human tumor cell populations by human granulocytes in vitro.
Chee DO; Townsend CM; Galbraith MA; Eilber FR; Morton DL
Cancer Res; 1978 Dec; 38(12):4534-9. PubMed ID: 569013
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the human macrophage. II. The in vitro cytotoxicity of macrophages.
Chang YC; Yao CS
Eur J Immunol; 1979 Jul; 9(7):521-5. PubMed ID: 291509
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes.
Petrie HT; Klassen LW; Kay HD
J Immunol; 1985 Jan; 134(1):230-4. PubMed ID: 3871101
[TBL] [Abstract][Full Text] [Related]
4. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
6. Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.
Ren-Heidenreich L; Davol PA; Kouttab NM; Elfenbein GJ; Lum LG
Cancer; 2004 Mar; 100(5):1095-103. PubMed ID: 14983507
[TBL] [Abstract][Full Text] [Related]
7. Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis.
Levy PC; Shaw GM; LoBuglio AF
J Immunol; 1979 Aug; 123(2):594-9. PubMed ID: 458149
[No Abstract] [Full Text] [Related]
8. Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells.
Takasugi M; Akira D; Kinoshita K
Cancer Res; 1975 Aug; 35(8):2169-76. PubMed ID: 1149032
[TBL] [Abstract][Full Text] [Related]
9. Characterization of natural cytotoxicity in vitro in a spontaneous rat tumor model.
Zöller M; Matzku S
J Immunol; 1980 Apr; 124(4):1683-90. PubMed ID: 6965955
[TBL] [Abstract][Full Text] [Related]
10. Cellular cytotoxicity and serum inhibition in normal mice following transfer of syngeneic tumor-sensitized cells.
Fisher B; Wolmark N; Saffer EA
J Natl Cancer Inst; 1980 Mar; 64(3):579-85. PubMed ID: 6986497
[TBL] [Abstract][Full Text] [Related]
11. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells.
Gunji Y; Gorelik E
Cancer Res; 1988 Sep; 48(18):5216-21. PubMed ID: 3409246
[TBL] [Abstract][Full Text] [Related]
12. In vitro spontaneous cytotoxic activity against mammalian target cells by the hemocytes of the solitary ascidian, Ciona intestinalis.
Peddie CM; Smith VJ
J Exp Zool; 1993 Dec; 267(6):616-23. PubMed ID: 8277232
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
Feinman R; Henriksen-DeStefano D; Tsujimoto M; Vilcek J
J Immunol; 1987 Jan; 138(2):635-40. PubMed ID: 3098851
[TBL] [Abstract][Full Text] [Related]
14. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
15. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
16. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
17. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
18. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
Evans R; Eidlen DM
J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated cytotoxicity of mononuclear cells isolated from cancer and normal mucosa of the stomach.
Sakai Y; Koizumi K
Gastroenterology; 1982 Jun; 82(6):1374-80. PubMed ID: 7067957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
